EN
HI
Eris Lifesciences Chart
Eris Lifesciences Share Key Metrics
Volume
69036.00
Market Cap
20315.93 CR
LTQ@LTP
9@1466.40
ATP
1466.72
Var Margin
16.42 %
Circuit Range
1168.8-1753.2
Delivery %
43.14 %
Value
10.13 CR
ASM/GSM
No
Market Lot
1
Summary
Eris Lifesciences share price is ₹1466.4 as of 25 Jun, 2026. The stock Eris Lifesciences intraday movement has stayed between ₹1450.80 and ₹1488.00, while on a 52-week basis,Eris Lifesciences price 52 week high is ₹1910.00 & its 52 week low is ₹1200.00.
In terms of trading activity, Eris Lifesciences has recorded a volume of 69036 shares, The Eris Lifesciences has a market cap of ₹138542887 CR. The stock’s Average Traded Price (ATP) stands at ₹1466.72, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 9 @ ₹1466.40.
Eris Lifesciences operates within a circuit range of ₹1168.80 – ₹1753.20, with a Value of ₹10.13 CR. The Delivery Percentage for the day is 43.14%. Additionally, Eris Lifesciences currently falls under the No framework, and trades with a market lot size of 1.
Eris Lifesciences Fundamentals
P/E Ratio
32.65
P/B Ratio
5.18
Div. Yield
0.49
Sector P/E
70.34
Sector P/B
3.13
Sec. Div. Yield
0.53
Eris Lifesciences Resistance and Support
Pivot 1459.8
Resistance
First Resistance
1486.2
Second Resistance
1511.4
Third Resistance
1537.8
Support
First Support
1434.6
Second Support
1408.2
Third Support
1383
Eris Lifesciences Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-20 | Audited Results & Interim Dividend |
| 2026-02-13 | Quarterly Results |
| 2025-11-24 | Preferential issue of shares |
| 2025-11-12 | Quarterly Results |
| 2025-08-05 | Quarterly Results |
| 2025-05-19 | Audited Results |
| 2025-02-07 | Interim Dividend |
| 2025-02-04 | Quarterly Results |
Eris Lifesciences News
Eris Lifesciences Ltd - 540596 - Corporate Presentation
Eris Lifesciences released its corporate presentation, outlining its strategic priorities, market leadership in Anti-Diabetes, successful Semaglutide launch, and FY27 guidance for 18-20% revenue growth and 37% EBITDA margin.
Jun 23 2026 16:17:04
Eris Lifesciences Ltd - 540596 - Compliances-Reg. 57 (1) - Certificate of interest payment/Principal in case of NCD
Eris Lifesciences announced the routine payment of annual interest amounting to Rs.54.56 crore on its outstanding Non-convertible Debentures. The payment was made on the due date of June 08, 2026, confirming the company is meeting its debt obligations.
Jun 08 2026 15:31:34
Read More
Eris Lifesciences Management
| Name | Position |
|---|---|
| Milind Talegaonkar | Company Secretary & Compliance Officer |
| Krishnakumar Vaidyanathan | Whole Time Director & COO |
Eris Lifesciences Similar Stocks
Acutaas Chemicals Ltd.
3268.60
-8.60 (0.26%)
Sai Life Sciences Ltd.
1205.00
-12.60 (1.03%)
Neuland Laboratories Ltd.
18072.00
-30.00 (0.17%)
Piramal Pharma Ltd.
172.44
3.55 (2.10%)
Pfizer Ltd.
4507.20
10.20 (0.23%)
Granules India Ltd.
770.85
-17.15 (2.18%)
Caplin Point Laboratories Ltd.
2519.00
28.10 (1.13%)
Astrazeneca Pharma India Ltd.
8442.00
-71.00 (0.83%)
Eris Lifesciences FAQs
The Buying Price of Eris Lifesciences share is 1466.4 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Eris Lifesciences stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Eris Lifesciences, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Eris Lifesciences shares is 32.65. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Eris Lifesciences shares is 5.18. Useful to assess the stock's value relative to its book value.
To assess Eris Lifesciences’s valuation compare Sector P/E, P/B which are 70.34 & 3.13 with sector averages, along with growth rates and financial metrics.
The Market Cap of Eris Lifesciences is 20315.93 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Eris Lifesciences share price is 1910.00 & 1200.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Eris Lifesciences belongs to the Healthcare sector.
Made for Traders.
Trusted by Investors.
Download FinX — trade confidently, invest
smarter, track everything.
